Co-Authors
This is a "connection" page, showing publications co-authored by John Laffey and Gerard Curley.
Connection Strength
1.644
-
The authors reply. Crit Care Med. 2017 07; 45(7):e737-e738.
Score: 0.723
-
A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial. Trials. 2021 Apr 19; 22(1):288.
Score: 0.235
-
Prone positioning improves oxygenation and lung recruitment in patients with SARS-CoV-2 acute respiratory distress syndrome; a single centre cohort study of 20 consecutive patients. BMC Res Notes. 2021 Jan 09; 14(1):20.
Score: 0.231
-
Modulating the distribution and fate of exogenously delivered MSCs to enhance therapeutic potential: knowns and unknowns. Intensive Care Med Exp. 2019 Jul 25; 7(Suppl 1):41.
Score: 0.209
-
Mesenchymal stem cells enhance NOX2-dependent reactive oxygen species production and bacterial killing in macrophages during sepsis. Eur Respir J. 2018 04; 51(4).
Score: 0.191
-
Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial. Trials. 2020 Jun 03; 21(1):462.
Score: 0.055